Source:http://linkedlifedata.com/resource/pubmed/id/16129777
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2005-10-7
|
pubmed:abstractText |
The authors describe the use of modified baculoviruses containing mammalian expression cassettes (BacMam technology) in steroid nuclear receptor reporter assays designed for screening and profiling agonist and antagonist compounds. Baculo-viruses were constructed that express full-length human genes for mineralocorticoid receptor (MR), glucocorticoid receptor (GR), progesterone receptor A (PR-A), and progesterone receptor B (PR-B) from the cytomegalovirus immediate early promoter. A virus carrying the mouse mammary tumor virus-firefly luciferase (MMTV-Luc) cassette was generated to provide a suitable reporter construct. Feasibility studies with BacMam-MR in single-dose tests of 1000 compounds showed high correlation to the standard transfection-based assay results. Likewise, in dose-response experiments, BacMam-based assays for GR and PR-B produced potency and efficacy values similar to transfection assay results. At various receptor/reporter ratios, the BacMam assays showed good flexibility, demonstrating consistent signal-to-background (S/B) ratios and compound potencies. Increasing transduction time from 24 to 48 h provided no benefit, actually reducing overall assay performance as measured by S/B and Z' values. The BacMam technology was applied in studies of isoforms PR-A and PR-B, which showed similar responses to a series of agonists. Taken together, the results demonstrate the utility of steroid nuclear receptor BacMam constructs for compound screening procedures with high reproducibility, reduced turnaround time, and lower cost.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1087-0571
|
pubmed:author |
pubmed-author:Barbo CosialJJ,
pubmed-author:CairnsWilliam JWJ,
pubmed-author:CaivanoMatildeM,
pubmed-author:ClayWilliam CWC,
pubmed-author:CondreayJ PatrickJP,
pubmed-author:GrayDavid WDW,
pubmed-author:KatsoRoy MRM,
pubmed-author:MasonSarah JSJ,
pubmed-author:MerrihewRaymond VRV,
pubmed-author:ParhamJanet HJH,
pubmed-author:RiegerJenniferJ,
pubmed-author:WakesNicole CNC
|
pubmed:issnType |
Print
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
715-24
|
pubmed:dateRevised |
2011-5-23
|
pubmed:meshHeading |
pubmed-meshheading:16129777-Animals,
pubmed-meshheading:16129777-Baculoviridae,
pubmed-meshheading:16129777-Cell Line,
pubmed-meshheading:16129777-Cell Line, Tumor,
pubmed-meshheading:16129777-Cercopithecus aethiops,
pubmed-meshheading:16129777-DNA, Recombinant,
pubmed-meshheading:16129777-Humans,
pubmed-meshheading:16129777-Protein Isoforms,
pubmed-meshheading:16129777-Receptors, Progesterone,
pubmed-meshheading:16129777-Transduction, Genetic,
pubmed-meshheading:16129777-Transfection
|
pubmed:year |
2005
|
pubmed:articleTitle |
Evaluation of cell-based assays for steroid nuclear receptors delivered by recombinant baculoviruses.
|
pubmed:affiliation |
Assay Development and Compound Profiling, GlaxoSmithKline, Stevenage, Hertfordshire, UK.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|